FAYUVI
LIVE

Serial Number

98806913

Owner

Ultragenyx Pharmaceutical Inc.

Attorney

John Paul Oleksiuk

Filing Date

Oct 17, 2024

Add to watchlist:

No watchlists yet
View on USPTO

FAYUVI Trademark

Serial Number: 98806913

FAYUVI is a trademark filed by Ultragenyx Pharmaceutical Inc. on October 17, 2024. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Ultragenyx Pharmaceutical Inc. (60 trademarks)

Novato, CA 94949

Entity Type: 03

Trademark Details

Filing Date

October 17, 2024

Registration Date

Not Registered

Published for Opposition

May 6, 2025

Goods & Services

Pharmaceutical, scientific, and medical research and development in the field of genetic, central nervous system, and lysosomal storage diseases and disorders; scientific research in the nature of conducting clinical trials for others in the field of genetic, central nervous system, and lysosomal storage diseases and disorders; scientific and medical research, namely, compiling and sharing of patient data for research purposes in the field of genetic, central nervous system, and lysosomal storage diseases and disorders; providing medical and scientific research information in the field of genetic, central nervous system, and lysosomal storage diseases and disorders; providing medical research and scientific research information in the field of genetic, central nervous system, and lysosomal storage diseases and disorders; pharmaceutical, scientific, and medical research and development in the field of gene therapy manufacturing technology; biomedical and scientific research in the fields of gene therapy, genetic, central nervous system, and lysosomal storage diseases and disorders; biomedical research in the field of gene therapy design and delivery; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; scientific research in the nature of conducting clinical trials for others in the field of gene therapy design and delivery

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 7, 2025 EXRA
SOU EXTENSION 1 GRANTED
Oct 6, 2025 EX1G
SOU EXTENSION 1 FILED
Oct 6, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 6, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 1, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 6, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 6, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 30, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 5, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 31, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 31, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 31, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 25, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 25, 2025 GNRT
NON-FINAL ACTION WRITTEN
Mar 25, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 24, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 17, 2024 NWOS
NEW APPLICATION ENTERED
Oct 17, 2024 NWAP